National Health Investors (NYSE:NHI) Sets New 12-Month High – Time to Buy?

National Health Investors, Inc. (NYSE:NHI) hit a new 52-week high on Thursday . The stock traded as high as $80.68 and last traded at $80.65, with a volume of 30272 shares changing hands. The stock had previously closed at $79.23.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research report on Monday, December 29th. National Bankshares set a $90.00 target price on shares of National Health Investors in a research note on Wednesday, October 1st. KeyCorp raised their price target on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Truist Financial raised their target price on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a report on Monday, December 15th. Finally, Wells Fargo & Company increased their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $86.50.

National Health Investors Price Performance

The company has a debt-to-equity ratio of 0.74, a current ratio of 10.64 and a quick ratio of 10.64. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 25.26, a PEG ratio of 3.00 and a beta of 0.67. The business’s fifty day moving average price is $77.80 and its 200-day moving average price is $75.95.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.08. The business had revenue of $83.36 million during the quarter, compared to the consensus estimate of $85.66 million. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The firm’s quarterly revenue was down 1.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, research analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. National Health Investors’s dividend payout ratio (DPR) is presently 116.09%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Metis Global Partners LLC raised its position in shares of National Health Investors by 34.1% in the 2nd quarter. Metis Global Partners LLC now owns 7,719 shares of the real estate investment trust’s stock valued at $541,000 after purchasing an additional 1,964 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of National Health Investors by 267.4% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,508 shares of the real estate investment trust’s stock valued at $316,000 after buying an additional 3,281 shares during the last quarter. Stephens Inc. AR increased its position in shares of National Health Investors by 10.8% in the 2nd quarter. Stephens Inc. AR now owns 8,662 shares of the real estate investment trust’s stock valued at $607,000 after acquiring an additional 842 shares during the period. Strs Ohio acquired a new position in shares of National Health Investors in the 1st quarter valued at $598,000. Finally, Monument Capital Management acquired a new stake in National Health Investors during the 2nd quarter worth about $252,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.